Kamakshi Sachidanandam

发表

The relationship of vascular structure, mechanics and function in resistance arteries in type 2 diabetes

Kamakshi Sachidanandam, 2008 .

Differential Effects of Diet-Induced Dyslipidemia and Hyperglycemia on Mesenteric Resistance Artery Structure and Function in Type 2 Diabetes

A. Ergul, M. Wang, Jim R. Hutchinson, 2009, Journal of Pharmacology and Experimental Therapeutics.

Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

A. Ergul, Alex K. Harris, V. Portik-Dobos, 2008, American journal of physiology. Heart and circulatory physiology.

Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes

A. Ergul, Weiguo Li, Kamakshi Sachidanandam, 2011, Neurological research.

Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

A. Ergul, Alex K. Harris, Weiguo Li, 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

A. Dorrance, A. Ergul, K. Motamed, 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

A. Ergul, V. Portik-Dobos, A. Kelly-Cobbs, 2010, Canadian journal of physiology and pharmacology.

Unexpected doxorubicin-mediated cardiotoxicity in sisters: Possible role of polymorphisms in histamine n-methyl transferase

J. Kolesar, H. Robins, Kamakshi Sachidanandam, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Unexpected doxorubicin-induced cardiomyopathy in sisters

J. Kolesar, H. Robins, Kamakshi Sachidanandam, 2012, International Cancer Conference Journal.

Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.

G. Wilding, J. Kolesar, J. Eickhoff, 2011, Experimental and therapeutic medicine.

Formation of endothelial lumens requires a coordinated PKCϵ-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation

Amber N. Stratman, G. Davis, D. Cheresh, 2009, Journal of Cell Science.

Differential effects of ETA and ETB receptor antagonism on oxidative stress in type 2 diabetes

A. Ergul, Daniel R. Malcom, David J. Rychly, 2007 .

Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A 549 cells

J. Kolesar, Zhisheng Jiang, R. Ikeda, 2022 .

Oxidative stress and cardiovascular disease: antioxidants and unresolved issues.

A. Ergul, S. Fagan, Kamakshi Sachidanandam, 2006, Cardiovascular drug reviews.

Evidence for Vasculoprotective Effects of ETB Receptors in Resistance Artery Remodeling in Diabetes

A. Ergul, Alex K. Harris, V. Portik-Dobos, 2007, Diabetes.

Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.

A. Dorrance, D. Stepp, A. Ergul, 2005, Diabetes.

Microvascular Versus Macrovascular Dysfunction in Type 2 Diabetes: Differences in Contractile Responses to Endothelin-1

A. Ergul, Alex K. Harris, Jim R. Hutchinson, 2006, Experimental biology and medicine.

Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial.

J. Kolesar, A. Argiris, J. Gilbert, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endothelial Endothelin B Receptor-Mediated Prevention of Cerebrovascular Remodeling Is Attenuated in Diabetes Because of Up-Regulation of Smooth Muscle Endothelin Receptors

A. Ergul, Alex K. Harris, V. Portik-Dobos, 2011, Journal of Pharmacology and Experimental Therapeutics.

Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.

A. Ergul, Daniel R. Malcom, David J. Rychly, 2007, Vascular pharmacology.

Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.

J. Kolesar, Zhisheng Jiang, R. Ikeda, 2011, International Journal of Oncology.